Low prevalence of complications in severe neutropenic children with cancer in the unprotected environment of an overnight camp

Pediatric Blood and Cancer

Volumn 48, Issue 2, 2007, Pages 148-151

  Tabori, Uri ^a   Jones, Heather ^a   Malkin, David ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Bleeding; Camp; Cancer; Fever; Neutropenia

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; HYDROXYUREA; TEMOZOLOMIDE; TOPOTECAN; VINBLASTINE;

ADOLESCENT; ARTICLE; BLEEDING; BRAIN TUMOR; CAMPING; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FEVER; HOSPITALIZATION; HUMAN; INFECTION; INFECTION RISK; MALE; NEUTROPENIA; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLID TUMOR;

ADOLESCENT; CHILD; FEASIBILITY STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFECTION; MALE; NEOPLASMS; NEUTROPENIA; RECREATION;

EID: 33845640607     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20757     Document Type: Article

References (16)

1. Hvizdala EV, Miale TD, Barnard PJ. A summer camp for children with cancer. Med Pediatr Oncol 1978;4:71-75.
2. Martiniuk AL. Camping programs for children with cancer and their families. Support Care Cancer 2003;11:749-757.
3. Lishner K, Busch K. Safe delivery of medications to children in summer camps. Pediatr Nurs 1994;20:249-253.
4. Rolston KV. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: Salient features and comments. Clin Infect Dis 2004;39:S44-S48.
5. Steels M. Oncologic emergencies. In: Cheng A, Williams B, Sivarajan B, editors. HSC Handbook of Pediatrics, 10th edn. Toronto: Elsevier Canada, 2003. pp 619-622.
6. Bodey GP, Buckley M, Sathe YS, et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-340.
7. Dietrich M, Gaus W, Vossen J, et al. Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: Clinical results. Infection 1977;5:107-114.
8. Levine AS, Siegel SE, Schreiber AD, et al. Protected environments and prophylactic antibiotics. A prospective control led study of their utility in the therapy of acute leukemia. N Engl J Med 1973;288:477-483.
9. Schimpff SC, Greene WH, Young VM, et al. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med 1975;82:351-358.
10. Moody K, Charlson ME, Finlay J. The neutropenic diet: What's the evidence? J Pediatr Hematol Oncol 2002;24:717-721.
11. Pizzo PA. Considerations for the prevention of infectious complications in patients with cancer. Rev Infect Dis 1989;11:S1551-S1563.
12. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-1332.
13. Heath JA, Steinherz PG, Altman A, et al. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: A Children's Cancer Group Study. J Clin Oncol 2003;21:1612-1617.
14. Hutchinson RJ, Gaynon PS, Sather H, et al. Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: Long-term follow-up of patients treated on Children's Cancer Group Trial 1881. J Clin Oncol 2003;21:1790-1797.
15. Kocak U, Rolston KV, Mullen CA. Fever and neutropenia in children with solid tumors is similar in severity and outcome to that in children with leukemia. Support Care Cancer 2002;10:58-64.
16. Loss JF, Santos PP, Leone LD, et al. Outcome of pediatric recurrent and refractory malignant solid tumors following ifosfamide/carboplatin/etoposide (ICE): A phase II study in a pediatric oncology centre in Brazil. Pediatr Blood Cancer 2004;42:139-144.